New drug tested to tame debilitating autoimmune disease
NCT ID NCT01782235
Summary
This study tested whether a drug called tocilizumab could help control the disease activity of primary Sjögren's syndrome, an autoimmune condition that causes severe dryness, pain, and fatigue. It involved 110 adults with moderate-to-severe disease activity. Participants were randomly assigned to receive either the study drug or a placebo to see if blocking a specific immune signal (IL-6) could improve their symptoms and overall disease burden.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY SJÖGREN'S SYNDROME (PSS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpitaux Universitaires de Strasbourg
Strasbourg, 67098, France
Conditions
Explore the condition pages connected to this study.